. 2007 Oct 8;65(4):548–557. doi: 10.1111/j.1365-2125.2007.03039.x

Table 3.

Evolution of short-term efficacy (during the first 2 weeks of treatment) and toxicity (from 4 weeks before to 4 weeks after initiating treatment) and significance of this evolution

	Basal value		Value at week 2 or 4		Variation
	Median	Range	Median	Range	Median	Range	Test P
HIV RNA (log₁₀ copies ml⁻¹)	4.86	2.95–6.04	2.93	1.60–4.57	1.80	1.25–2.73	<10⁻⁴
Glycaemia (mmol l⁻¹)	4.95	3.70–6.20	4.85	4.20–6.80	0.21	−1.5–1.7	0.05
Total cholesterol (mmol l⁻¹)	3.95	2.00–6.60	4.90	2.50–7.70	0.81	−1.49–3.7	10⁻⁴
HDL-cholesterol (mmol l⁻¹)	1.17	0.46–1.92	1.28	0.39–2.20	0.01	−1.53–1.69	0.17
Triglycerides (mmol l⁻¹)	0.90	0.29–1.91	1.23	0.44–2.45	0.20	−0.68–1.17	0.20